Edition:
India

T2 Biosystems Inc (TTOO.OQ)

TTOO.OQ on NASDAQ Stock Exchange Global Market

4.26USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
59,068
52-wk High
$6.97
52-wk Low
$2.51

Chart for

About

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including... (more)

Overall

Beta: --
Market Cap(Mil.): $157.07
Shares Outstanding(Mil.): 35.14
Dividend: --
Yield (%): --

Financials

BRIEF-T2 Biosystems Q3 loss per share $0.45

* T2 biosystems reports third quarter 2017 financial results and provides company update

03 Nov 2017

BRIEF-T2 Biosystems announces pricing of public offering of common stock

* T2 Biosystems announces pricing of public offering of common stock

15 Sep 2017

BRIEF-T2 Biosystems announces proposed public offering of common stock

* T2 Biosystems announces proposed public offering of common stock Source text for Eikon: Further company coverage:

15 Sep 2017

BRIEF-T2 Biosystems submits 510(K) application to the FDA for review of T2Bacteria Panel

* T2 Biosystems submits 510(K) application to the FDA for review of T2Bacteria Panel‍​ Source text for Eikon: Further company coverage:

11 Sep 2017

BRIEF-T2 Biosystems to collaborate with CDC to detect emerging superbug Candida Auris​

* T2 Biosystems Inc - ‍announces collaboration with CDC to detect emerging superbug Candida Auris​ Source text for Eikon: Further company coverage:

06 Sep 2017

BRIEF-T2 Biosystems entered into amendment to supply agreement as of Oct 10, 2014

* On August 29, Co & Smc Ltd entered into amendment to supply agreement amending certain supply agreement, dated as of Oct 10, 2014

06 Sep 2017

Earnings vs. Estimates